Integral Health Asset Management, LLC Heron Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $798,000 - $1.61 Million	-300,000 Reduced 30.0%	700,000 $2.95 Million
Q1 2022 May 12, 2022	BUY	$4.63 - $9.94 $1.16 Million - $2.49 Million	250,000 Added 33.33%	1,000,000 $5.72 Million
Q4 2021 Feb 02, 2022	BUY	$8.35 - $12.6 $2.84 Million - $4.28 Million	340,000 Added 82.93%	750,000 $6.85 Million
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $3.14 Million - $4.65 Million	310,000 Added 310.0%	410,000 $4.38 Million
Q2 2021 Aug 30, 2021	SELL	$13.27 - $18.48 $1.33 Million - $1.85 Million	-100,000 Reduced 50.0%	100,000 $1.55 Million
Q2 2021 Aug 13, 2021	BUY	$13.27 - $18.48 $2.65 Million - $3.7 Million	200,000 New	200,000 $3.1 Million

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.